Molecule intelOpportunity: Lower0

Sildenafil

10 brands · 9 companies · product forms

Opportunity snapshot

Launch attractiveness
34
Market saturation
23
Price room
80
Regulatory risk
0
10
brands
9
companies
Rs 250
median price
3
price points
4.21x
price spread
90
confidence %

Who competes here

Top companies by brand count · leader share 20%

Price room

Across observed sources and strengths
CheapestRs 190
MedianRs 250
Most expensiveRs 800
Spread4.21×
Sources: DVAGO

max/min price ratio 4.21x across 3 trusted points (Rs 190.0-800.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 4 live products for Sildenafil — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(80) + 20% low-competition(77) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

9 canonical companies and 10 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 4.21x across 3 trusted points (Rs 190.0-800.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.